关于JSR Life Sciences
了解我们
JSR Life Sciences brings together the deep biochemical knowledge and understanding of human disease, expertise in drug discovery and development, and access to capital into a single, integrated framework that creates value for our customers.
JSR supports the drug discovery and development needs of our partners with tailored solutions that identifies and applies the right tools and technologies to support their unique therapeutic programs. From de-risking molecule selection and accelerating biologic development timelines, to increasing clinical success rates and developing in vitro diagnostics, JSR Life Sciences is committed to guiding our customers’ innovative science along the path to becoming life-saving medicines.
Accelerating Our Life Sciences Footprint
We offer our partners best-in-class research products and services for outsourced drug discovery and development. With our proprietary products and services and through our affiliate companies, JSR has a global presence including 28 sites in seven countries.
Our Affiliates
We leverage the core competencies of our affiliates to create integrated solutions that are designed to guide our partners’ programs from the lab through commercialization.
Crown Bioscience
Contract research organization with advanced technology for precision medicine
Similis Bio
Similis Bio jump-starts your biosimilar program with pre-qualified analytical methods, detailed reference product characterization & off-the-shelf assets.
MBL
Biomarker discovery for companion and in vitro diagnostics
KBI Biopharma
Global contract development and manufacturing organization with advanced analytical capabilities
JSR’s specialty life science research products include:
Amsphere A3, a protein A chromatography resin for advanced protein separation
Magnosphere hydrophilic and hydrophobic microparticles for research and in vitro diagnostics use
JSR Life Sciences is a business unit of JSR Corporation, a multinational advanced materials and solutions company based in Japan.
JSR Life Sciences最新新闻
冠科生物与 NEXT Oncology 深化合作伙伴关系
Crown Bioscience 和 NEXT Oncology 重新展开合作，结合全球临床试验专业知识和创新癌症模型进行肿瘤药物开发。
荣膺全球生物药生产领军企业称号
JSR 生命科学旗下公司 KBI Biopharma 在 2025 年 CDMO 领导力奖中因其在生物制剂制造领域的卓越表现而获得全球认可。